Spruce Biosciences, Inc. · NASDAQ:SPRB
Citadel Advisors LLC reported a 9.99% stake in Spruce Biosciences, Inc. (Schedule 13G)
Event Oct 9, 2025 · Filed Oct 16, 2025
Citadel Advisors LLC reported a 9.99% stake in Spruce Biosciences, Inc., 109,649 shares, as a passive investor on Oct 9, 2025. Filed Oct 16, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 109,649
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 7 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Citadel Advisors LLC | 9.99% | 109,649 |
| Citadel Advisors Holdings LP | 9.99% | 109,649 |
| Citadel GP LLC | 9.99% | 109,649 |
| Citadel Securities LLC | 0% | 0 |
| Citadel Securities Group LP | 0% | 0 |
| Citadel Securities GP LLC | 0% | 0 |
| Kenneth Griffin | 9.99% | 109,649 |
Source
Related
- Spruce Biosciences, Inc.
- Citadel Advisors LLC
- Spruce Biosciences, Inc. shareholders
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Citadel Advisors LLC · May 15, 2026
- Schedule 13G/A · Citadel Advisors LLC · Feb 17, 2026
- Schedule 13G · AWM Investment Company, Inc. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Millennium Management LLC · Aug 4, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026